Molecular Partners Publishes Invitation to Annual General Meeting 2025
Provided By GlobeNewswire
Last update: Mar 25, 2025
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today published the invitation to the Annual General Meeting 2025.
Read more at globenewswire.com
